CAPRION PHARMACUETICALS ANNOUNCES NEW COLLABORATION WITH ASTRAZENECA

Caprion Pharmaceuticals Inc. today announced a collaboration agreement with AstraZeneca focused on the discovery of novel targets for the treatment of prostate cancer. The collaboration seeks to enable the development of innovative therapies, providing both AstraZeneca and Caprion with new candidates for their development pipelines.

Yahoo News (http://biz.yahoo.com/bw/051101/15389.html?.v=1)